Status
Conditions
About
Cognitive impairment is the core symptom of unipolar and bipolar depression, which seriously affects the prognosis of the disease and the rehabilitation of social function. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. In this study,the THINC-it tool was used to study the characteristics of cognitive impairment in unipolar and bipolar depression by longitudinal follow-up, which provides a theoretical basis for the differential diagnosis of unipolar and bipolar depression. Early identification and intervention of risk factors can improve the prognosis of the disease.
Full description
there is some cognitive impairment in patients with unipolar and bipolar depression. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. The THINC-it is a simple, fast and free cognitive assessment tool for cognitive impairment screening of unipolar and bipolar depression.
This study includes three steps.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Case group:
1、Participants in psychiatric outpatients and inpatients are able and willing to provide informed consent.
The participants were male or female aged between 18 and 60, with junior high school education or above.
According to ICD-10 criteria, participants were diagnosed with Unipolar and bipolar depressive disorder.
The total score of Young's Mania scale ((YMRS)) of the participants was less than 5 and HAMD-17 was greater than17.
Subjects received stable mood stabilizers at least two weeks before the study visit, such as SSRIs antidepressants.
The combination or use of supportive psychotherapy is allowed.
Control group:
1.it did not meet any of the diagnostic criteria in ICD-10 in the past or at present.
2.18-60 years old, junior high school education or above. 3.Have sufficient audio-visual skills to complete the necessary examinations of the study.
4.Willing to participate in this study, and the informed consent form was signed by the subjects.
Exclusion criteria
120 participants in 3 patient groups
Loading...
Central trial contact
Jun Chen, M.D., Ph.D; Na Zhu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal